EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,468,259 | -49.4% | 471,872 | -28.7% | 0.02% | -52.9% |
Q1 2023 | $6,855,958 | +19.0% | 661,772 | +35.6% | 0.03% | +6.2% |
Q4 2022 | $5,761,875 | -6.1% | 487,881 | +66.9% | 0.03% | -3.0% |
Q3 2022 | $6,135,000 | -39.3% | 292,277 | -10.2% | 0.03% | -36.5% |
Q2 2022 | $10,104,000 | -16.0% | 325,508 | +11.1% | 0.05% | -23.5% |
Q1 2022 | $12,030,000 | +44.9% | 292,987 | +53.4% | 0.07% | +51.1% |
Q4 2021 | $8,300,000 | -12.4% | 190,941 | +0.9% | 0.04% | -26.2% |
Q3 2021 | $9,474,000 | -23.7% | 189,213 | -4.0% | 0.06% | -29.1% |
Q2 2021 | $12,411,000 | +36.9% | 197,027 | +124.5% | 0.09% | +14.7% |
Q3 2020 | $9,067,000 | +2330.8% | 87,748 | +1762.2% | 0.08% | +1775.0% |
Q2 2020 | $373,000 | -39.1% | 4,712 | -55.5% | 0.00% | -77.8% |
Q1 2020 | $612,000 | +70.9% | 10,583 | +59.7% | 0.02% | +157.1% |
Q4 2019 | $358,000 | -79.4% | 6,628 | -80.1% | 0.01% | -76.7% |
Q3 2019 | $1,742,000 | +127.4% | 33,324 | +110.0% | 0.03% | +42.9% |
Q2 2019 | $766,000 | – | 15,866 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |